Adage Capital Partners Gp, L.L.C. Tango Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $59.7 Billion
- Q3 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,511,000 shares of TNGX stock, worth $20.5 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,511,000
Previous 5,905,349
57.48%
Holding current value
$20.5 Million
Previous $30.2 Million
30.24%
% of portfolio
0.04%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding TNGX
# of Institutions
148Shares Held
130MCall Options Held
170KPut Options Held
17.6K-
Trv Gp Iv, LLC Boston, MA13.9MShares$113 Million100.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA10.8MShares$87.9 Million0.39% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$86.9 Million6.71% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA8.54MShares$69.7 Million8.04% of portfolio
-
Woodline Partners LP San Francisco, CA6.03MShares$49.3 Million0.26% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $720M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...